Development of CellRADx as a Tool for Dose Assessment and Triage

ASELL is a leader in the development of in vitro diagnostics for biodosimetry. ASELL has been developing the CellRADx™ point-of-care biodosimetry diagnostic test in collaboration with the Armed Forces Radiobiology Research Institute (AFRRI) to increase national preparedness to respond to a mass-casualty radiological or nuclear incident.
Dr. William F. Blakely from AFRRI was invited to speak at the 2025 Military Health System Research Symposium (MHSRS) in Orlando, Florida about the ongoing development of the CellRADx test.

To learn more, click the link below to view and download his presentation, “Development of CellRADx as a Tool for Dose Assessment and Triage.”